Abstract
Objectives: Inflammation plays a role in prematurity, in neonatal disorders of the brain, lung,
eye, bowel, and in developmental disability among preterm infants. We initiated a
pilot study in preterm children to determine the prevalence of single nucleotide polymorphisms
(SNPs) in the infection/inflammation-associated genes for interleukin (IL)-10 (- 1082
G/A), IL-1β (+ 3953 C/T), tumor necrosis factor (TNF)-α (- 308 G/A) and toll-like
receptor 4 (TLR-4) (Asp299Gly) and whether these SNPs affect the risk for neonatal
disorders. Study Design: We genotyped 73 children ≥ 2 years of age whose gestational age at birth was < 32
weeks, and explored the associations between genotypes and neonatal disorders and
developmental status at age 2 + years. Results: Infants homozygous for the high IL-10 producer - 1082 G‐allele (n = 15) were significantly
less likely to develop ultrasound-defined periventricular echodensities. A non-significant,
but prominent, risk reduction for bronchopulmonary dysplasia, high-grade retinopathy,
cerebral palsy, and developmental delay at age 2 + years was present. Polymorphisms
in the IL-1β, TNF-α, and TLR-4 genes were too infrequent in our pilot sample to allow
for reasonable analysis. Conclusion: Infants homozygous for the IL-10 high producer - 1082 G allele might be at reduced
risk for prematurity-associated disorders.
Key words
Infant - premature - brain - cytokine - polymorphism
References
- 1
An H, Nishimaki S, Ohyama M, Haruki A, Naruto T, Kobayashi N. et al .
Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptor-I in the
cord blood as predictors of chronic lung disease in premature infants.
Am J Obstet Gynecol.
2004;
191
1649-1654
- 2
Arbour N C, Lorenz E, Schutte B C, Zabner J, Kline J N, Jones M. et al .
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.
Nat Genet.
2000;
25
187-191
- 3
Bancalari E, Claure N, Sosenko I RS.
Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition.
Semin Neonatol.
2003;
8
63-71
- 4
Bos A F, Martijn A, Okken A, Prechtl H F.
Quality of general movements in preterm infants with transient periventricular echodensities.
Acta Paediatrica.
1998;
87
328-335
- 5
Chen C C, Huang C B, Chung M Y, Huang L T, Yang C Y.
Periventricular echogenicity is related to delayed neurodevelopment of preterm infants.
Am J Perinatol.
2004;
2
483-489
- 6
Dammann O, Leviton A.
Duration of transient hyperechoic images of white matter in very-low-birth weight
infants: a proposed classification.
Dev Med Child Neurol.
1997;
39
2-5
- 7
Dammann O, Leviton A.
Inflammatory brain damage in preterm newborns - dry numbers, wet lab, and causal inference.
Early Hum Dev.
2004;
79
1-15
- 8
De Vries L S, Van Haastert I L, Rademaker K J, Koopman C, Groenendaal F.
Ultrasound abnormalities preceding cerebral palsy in high-risk preterm infants.
J Pediatr.
2004;
144
815-820
- 9
Dommergues M A, Patkai J, Renauld J C, Evrard P, Gressens P.
Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the
newborn murine neopallium.
Ann Neurol.
2000;
47
54-63
- 10
Erickson S J, Grauaug A, Gurrin L, Swaminathan M.
Hypocarbia in the ventilated preterm infant and its effect on intraventricular haemorrhage
and bronchopulmonary dysplasia.
J Paediatr Child Health.
2002;
38
560-562
- 11
Fazzi E, Orcesi S, Caffi L, Ometto A, Rondini G, Telesca C. et al .
Neurodevelopmental outcome at 5 - 7 years in preterm infants with periventricular
leukomalacia.
Neuropediatrics.
1994;
25
134-139
- 12
Frankenburg W K, Dodds J, Archer P, Shapiro H, Bresnick B.
The Denver II: a major revision and restandardization of the Denver developmental
screening test.
Pediatrics.
1992;
89
91-97
- 13
Froen J F, Munkeby B H, Stray-Pedersen B, Saugstad O D.
Interleukin-10 reverses acute detrimental effects of endotoxin-induced inflammation
on perinatal cerebral hypoxia-ischemia.
Brain Res.
2002;
942
87-94
- 14
Goepfert A R, Andrews W W, Carlo W, Ramsey P S, Cliver S P, Goldenberg R L. et al
.
Umbilical cord plasma interleukin-6 concentrations in preterm infants and risk of
neonatal morbidity.
Am J Obstet Gynecol.
2004;
191
1375-1381
- 15
Goldenberg R L, Hauth J C, Andrews W W.
Intrauterine infection and preterm delivery.
N Engl J Med.
2000;
342
1500-1507
- 16
Goldstein B, Giroir B, Randolph A.
International pediatric sepsis consensus conference: definitions for sepsis and organ
dysfunction in pediatrics.
Pediatr Crit Care Med.
2005;
6
2-8
- 17
Gopel W, Kattner E, Seidenberg J, Kohlmann T, Segerer H, Moller J.
The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a
birth weight below 1500 g.
J Pediatr.
2002;
140
688-692
- 18
Hansen B M, Hoff B, Uldall P, Greisen G, Kamper J, Djernes B. et al .
Perinatal risk factors of adverse outcome in very preterm children: a role of initial
treatment of respiratory insufficiency?.
Acta Paediatr.
2004;
93
185-189
- 19
Harding D, Brull D, Humphries S E, Whitelaw A, Montgomery H, Marlow N.
Variation in the interleukin-6 gene is associated with impaired cognitive development
in children born prematurely: a preliminary study.
Pediatr Res.
2005;
58
117-120
- 20
ICROP .
An international classification of retinopathy of prematurity.
Pediatrics.
1984;
74
127-133
- 21
Inder T E, Anderson N J, Spencer C, Wells S, Volpe J J.
White matter injury in the premature infant: a comparison between serial cranial sonographic
and MR findings at term.
AJNR Am J Neuroradiol.
2003;
24
805-809
- 22
Jobe A H.
Antenatal factors and the development of bronchopulmonary dysplasia.
Semin Neonatol.
2003;
8
9-17
- 23
Jones C A, Cayabyab R G, Kwong K Y, Stotts C, Wong B, Hamdan H. et al .
Undetectable interleukin (IL)-10 and persistent IL‐8 expression early in hyaline membrane
disease: a possible developmental basis for the predisposition to chronic lung inflammation
in preterm newborns.
Pediatr Res.
1996;
39
966-975
- 24
Kerk J, Dordelmann M, Bartels D B, Brinkhaus M J, Dammann C EL, Dork T. et al .
Multiplex measurement of cytokine/receptor gene polymorphisms and interaction between
interleukin 10 (- 1082) genotype and chorioamnionitis in extreme preterm delivery.
J Soc Gynecol Investig.
2006;
13
350
- 25
Kreuzer C, Urlesberger B, Maurer U, Muller W.
(Transient periventricular echodensities [TPE] in preterm infants under 1500 gramms:
an analysis of the outcome of the last 10 years).
Klin Padiatr.
2003;
215
252-256
- 26
Kuban K C, Leviton A.
Cerebral palsy.
N Engl J Med.
1994;
330
188-195
- 27
Kwong K Y, Jones C A, Cayabyab R, Lecart C, Khuu N, Rhandhawa I. et al .
The effects of IL‐10 on proinflammatory cytokine expression (IL-1beta and IL‐8) in
hyaline membrane disease (HMD).
Clin Immunol Immunopathol.
1998;
88
105-113
- 28
Lai F F, Tsou K Y.
Transient periventricular echodensities and developmental outcome in preterm infants.
Pediatr Neurol.
1999;
21
797-801
- 29
Leviton A, Paneth N, Reuss M L, Susser M, Allred E N, Dammann O. et al .
Maternal infection, fetal inflammatory response, and brain damage in very low birth
weight infants.
Pediatric Research.
1999;
46
566-575
- 30
Lyng K, Munkeby B H, Saugstad O D, Stray-Pedersen B, Froen J F.
Effect of interleukin-10 on newborn piglet brain following hypoxia-ischemia and endotoxin-induced
inflammation.
Biol Neonate.
2005;
87
207-216
- 31
Maalouf E F, Duggan P J, Counsell S J, Rutherford M A, Cowan F, Azzopardi D. et al
.
Comparison of findings on cranial ultrasound and magnetic resonance imaging in preterm
infants.
Pediatrics.
2001;
107
719-727
- 32
Mesples B, Plaisant F, Gressens P.
Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice.
Brain Res Dev Brain Res.
2003;
141
25-32
- 33
Moore K W, de Waal Malefyt R, Coffman R L, O'Garra A.
Interleukin-10 and the interleukin-10 receptor.
Ann Rev Immunol.
2001;
19
683-765
- 34
Mormann M, Rieth H, Hua T D, Assohou C, Roupelieva M, Hu S L. et al .
Mosaics of gene variations in the Interleukin-10 gene promoter affect interleukin-10
production depending on the stimulation used.
Genes Immun.
2004;
5
246-255
- 35
Nelson K B, Dambrosia J M, Iovannisci D M, Cheng S, Grether J K, Lammer E.
Genetic polymorphisms and cerebral palsy in very preterm infants.
Pediatr Res.
2005;
57
494-499
- 36
Ogunyemi D, Murillo M, Jackson U, Hunter N, Alperson B.
The relationship between placental histopathology findings and perinatal outcome in
preterm infants.
J Matern Fetal Neonatal Med.
2003;
13
102-109
- 37
O'Shea T M, Kothadia J M, Roberts D D, Dillard R G.
Perinatal events and the risk of intraparenchymal echodensity in very-low-birth weight
neonates.
Paediatr Perinat Epidemiol.
1998;
12
408-421
- 38
Pinsky M R, Vincent J L, Deviere J, Alegre M, Kahn R J, Dupont E.
Serum cytokine levels in human septic shock. Relation to multiple-system organ failure
and mortality.
Chest.
1993;
103
565-575
- 39
Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J.
A TaqI polymorphism in the human interleukin-1 beta (IL‐1 beta) gene correlates with
IL‐1 beta secretion in vitro.
Eur J Clin Invest.
1992;
22
396-402
- 40
Resch B, Vollaard E, Maurer U, Haas J, Rosegger H, Muller W.
Risk factors and determinants of neurodevelopmental outcome in cystic periventricular
leucomalacia.
Eur J Pediatr.
2000;
159
663-670
- 41
Rodts-Palenik S, Wyatt-Ashmead J, Pang Y, Thigpen B, Cai Z, Rhodes P. et al .
Maternal infection-induced white matter injury is reduced by treatment with interleukin-10.
Am J Obstet Gynecol.
2004;
191
1387-1392
- 42
Sonnander K.
Early identification of children with developmental disabilities.
Acta Paediatr Suppl.
2000;
89
17-23
- 43
Speer C P.
Pre- and postnatal inflammatory mechanisms in chronic lung disease of preterm infants.
Paediatr Respir Rev.
2004;
5 (Suppl A)
S241-S244
- 44
Stoelhorst G M, Rijken M, Martens S E, van Zwieten P H, Feenstra J, Zwinderman A H.
et al .
Developmental outcome at 18 and 24 months of age in very preterm children: a cohort
study from 1996 to 1997.
Early Hum Dev.
2003;
72
83-95
- 45
Turner D M, Williams D M, Sankaran D, Lazarus M, Sinnott P J, Hutchinson I V.
An investigation of polymorphism in the interleukin-10 gene promoter.
Eur J Immunogenet.
1997;
24
1-8
- 46
Vohr B R, Wright L L, Dusick A M, Perritt R, Poole W K, Tyson J E. et al .
Center differences and outcomes of extremely low birth weight infants.
Pediatrics.
2004;
113
781-789
- 47
Voigt M, Schneider K T, Jahrig K.
[Analysis of a 1992 birth sample in Germany. 1: New percentile values of the body
weight of newborn infants].
Geburtsh Frauenheilkd.
1996;
56
550-558
- 48
Wilson A G, Symons J A, McDowell T L, McDevitt H O, Duff G W.
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional
activation.
Proc Natl Acad Sci USA.
1997;
94
3195-3199
- 49
Wu Y W.
Systematic review of chorioamnionitis and cerebral palsy.
Mental Retardation and Developmental Disabilities Research Reviews.
2002;
8
25-29
- 50
Yanamandra K, Boggs P, Loggins J, Baier R J.
Interleukin-10 - 1082 G/A polymorphism and risk of death or bronchopulmonary dysplasia
in ventilated very low birth weight infants.
Pediatr Pulmonol.
2005;
39
426-432
1 These two authors contributed equally
MD Michael Dördelmann
Department of Pediatric Pneumology and Neonatology
OE 6710
Hannover Medical School
30623 Hannover
Germany
Email: doerdelmann.michael@mh-hannover.de